Study of Antibody for Methamphetamine Outpatient Therapy
Clinical trial NCT03336866 · COMPLETED
Trial details
- NCT number
- NCT03336866
- Sponsor
- InterveXion Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2020-11-23
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.